PCVX vs AAPL: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Apple Inc in 2026
PCVX
Vaxcyte Inc
$62.35
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | PCVX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $9.03B | N/A | PCVX |
| P/E Ratio | N/A | 33.34 | AAPL |
| EPS (TTM) | $N/A | $7.90 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze PCVX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or AAPL a better investment?
Comparing PCVX and AAPL: Vaxcyte Inc has a market cap of $9.03B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and AAPL?
PCVX (Vaxcyte Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for PCVX.
Which company is more profitable: PCVX or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for PCVX.
Which is the larger company: PCVX or AAPL?
Vaxcyte Inc (PCVX) is larger with a market cap of $9.03B compared to N/A for AAPL.
Should I buy PCVX or AAPL in 2026?
Both PCVX and AAPL have investment merit. PCVX trades at $62.35 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and AAPL stock?
Key differences: Market Cap ($9.03B vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).